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background: Plasma brain natriuretic peptide (BNP) has been known as a sole biomarker for heart failure (HF). Recently, fibroblast growth factor 
23 (FGF23), a phosphate-regulating hormone, has been reported to be linked to HF per se and to renal dysfunction. The aim of this study was to 
examine whether the hemodynamic parameters in patients with HF are linked to either the FGF23 or BNP levels. 
Methods: We prospectively enrolled 154 hospitalized HF patients with relatively preserved renal function (eGFR >40 ml/min/1.73 m2). We 
performed right and left heart catheterizations, measured both the serum FGF23 and plasma BNP levels and did echocardiogram during their stable 
phase. We measured right arterial pressure (RAP), the diameter of the inferior vena cava (IVC) and its respiratory changes (RC) as the markers for 
right-sided cardiac function. We evaluated pulmonary artery pressure (PAP), pulmonary capillary wedge pressure (PCWP) and cardiac index (CI) as an 
index of left-sided cardiac function. 
results: FGF23 levels, but not BNP levels correlated with RAP (r=0.20, p=0.012), the diameter of IVC (r=0.31, p<0.001) and RC (p=0.008), 
whereas both FGF23 and BNP levels independently correlated with PAP (r=0.24, p=0.003 vs. r=0.29, p<0.001), PCWP (r=0.24, p=0.003 vs. r=0.35, 
p<0.001) and CI (r=-0.32, p<0.001 vs. r=-0.41, p<0.001). In addition, the frequency of cardiac event was significantly higher in high FGF23 group 
than that in low FGF23 group (Log rank p=0.039) as well as in high BNP group than in low BNP group (Log rank p=0.029). 
conclusions: The serum FGF23 levels were correlated with the hemodynamics associated with right-sided heart failure not only left-sided heart 
failure, whereas the plasma BNP levels were correlated only with the markers of left-sided heart failure. New pathophysiological information about 
cardiac dysfunction may be provided by FGF23 levels differs from by BNP levels.
